Pigments from Filamentous Ascomycetes for Combination Therapy
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F19%3A10400599" target="_blank" >RIV/00216208:11110/19:10400599 - isvavai.cz</a>
Alternative codes found
RIV/00027022:_____/18:N0000011 RIV/60461373:22340/19:43919261 RIV/00064165:_____/19:10400599
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Y~0zlp2UwN" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=Y~0zlp2UwN</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.2174/0929867325666180330091933" target="_blank" >10.2174/0929867325666180330091933</a>
Alternative languages
Result language
angličtina
Original language name
Pigments from Filamentous Ascomycetes for Combination Therapy
Original language description
Filamentous ascomycetes (Neurospora and Monascus) have been studied for a long time because of their production of secondary metabolites such as microbial pigments. The ascomycetes represent an interesting group of compounds with high potential for medicinal applications. Many recent studies have shown their efficacy in the treatment of serious pathological states such as oncological diseases, neurodegenerative diseases and hyperlipidaemia. Nevertheless, the clinical usability of ascomycetes is still limited. However, this problem can be solved by the use of these compounds with combinations of other therapeutic agents. This strategy can suppress their side effects and improve their therapeutic efficacy. Moreover, their co-application can significantly enhance conventional therapies that are used. This review summarizes and discusses the general principles of this approach, introduced and supported by numerous examples. In addition, the prediction of the future potential application of this methodology is included.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
10608 - Biochemistry and molecular biology
Result continuities
Project
<a href="/en/project/FV20572" target="_blank" >FV20572: Adjuvant therapy</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Current Medicinal Chemistry
ISSN
0929-8673
e-ISSN
—
Volume of the periodical
26
Issue of the periodical within the volume
20
Country of publishing house
NL - THE KINGDOM OF THE NETHERLANDS
Number of pages
23
Pages from-to
3812-3834
UT code for WoS article
000485822100010
EID of the result in the Scopus database
2-s2.0-85072600023